OA03.03 Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in Patients With Advanced NSCLC: Updated Results of TROPION-PanTumor01 Phase 1 Study

Alexander I. Spira, Aaron Lisberg, Jacob Sands, Jonathan Greenberg, Penny Phillips, F. Guevara, Naoyuki Tajima, Yui Kawasaki, Jiacheng Gu, F. Kobayashi, Noboru Yamamoto, Melissa L. Johnson, Funda Meric‐Bernstam, Kiyotaka Yoh, Edward B. Garon, Rebecca S. Heist, Toshio Shimizu